Regulatory affairs

MALVERN, PA — TELA Bio, Inc.(NASDAQ: TELA), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, …